SB

Srujan Bobbala

Active Director Director DIN 11402022
DIN 11402022 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Srujan Bobbala

Data last updated:

Srujan Bobbala is a Director at Medtronex Nutraceuticals Private Limited (since 2025) and Director at Chiprix Pharma Private Limited (since 2025). The companies operate in Pharma.

DIN 11402022
Primary Designation Director
Industry Pharma
First Appointment 29 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20252025Active
Chiprix Pharma Private Limited U21001TS2025PTC206873
Director29 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Medtronex Nutraceuticals Private Limited
Chiprix Pharma Private Limited
Premium access

Shareholding and investment profile for Srujan Bobbala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srujan Bobbala

Srujan Bobbala currently holds 2 directorships: Medtronex Nutraceuticals Private Limited (Director, since 17 Dec 2025); Chiprix Pharma Private Limited (Director, since 29 Nov 2025).

Srujan Bobbala was first appointed on 29 Nov 2025 as Director at Chiprix Pharma Private Limited.

The current boards of Srujan Bobbala's companies include Buthkuri Suresh Reddy (Medtronex Nutraceuticals Private Limited), Sreenivasulu Kurni (Medtronex Nutraceuticals Private Limited), Bobbala Divya (Chiprix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available